You must log in to view this page.

Viridian Therapeutics Inc

NASDAQ: VRDN    
Share price (5/16/24): $14.63    
Market cap (5/16/24): $934 million
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2024
Other Revised 05/15/24 Viridian Therapeutics, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 04:35 PM 05/15/24 Earnings Revised 05/08/24 Viridian Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 05/08/24 Other Revised 04/26/24 Viridian Therapeutics, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-11-2024 07:30 AM 01/11/24
CY 2023
Other Revised 12/18/23 Viridian Therapeutics, Inc. - Special Call 12/18/23 Other Revised 07/11/23 Viridian Therapeutics, Inc. - Special Call 07/10/23 Earnings Revised 05/10/23 Viridian Therapeutics, Inc., Q1 2023 Earnings Call, May 09, 2023 05/09/23 Earnings Revised 03/08/23 Viridian Therapeutics, Inc., Q4 2022 Earnings Call, Mar 08, 2023 03/08/23 Other Revised 01/09/23 Viridian Therapeutics, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-09-2023 02:15 PM 01/09/23
CY 2022
Earnings Revised 11/14/22 Viridian Therapeutics, Inc., Q3 2022 Earnings Call, Nov 14, 2022 11/14/22 Earnings Revised 08/15/22 Viridian Therapeutics, Inc., Q2 2022 Earnings Call, Aug 15, 2022 08/15/22 Earnings Revised 05/12/22 Viridian Therapeutics, Inc., Q1 2022 Earnings Call, May 12, 2022 05/12/22 Earnings Revised 03/10/22 Viridian Therapeutics, Inc., Q4 2021 Earnings Call, Mar 10, 2022 03/10/22
CY 2021
Other Revised 06/03/21 Viridian Therapeutics, Inc. - Shareholder/Analyst Call 06/03/21 Earnings Revised 03/25/21 Viridian Therapeutics, Inc., Q4 2020 Earnings Call, Mar 25, 2021 03/25/21 Other Revised 03/03/21 Viridian Therapeutics, Inc. Presents at Cowen 41st Annual Health Care Conference, Mar-03-2021 11:40 AM 03/03/21
CY 2020
Other Revised 12/31/20 Miragen Therapeutics, Inc. - Shareholder/Analyst Call 12/31/20 Other Revised 10/28/20 Miragen Therapeutics, Inc., Viridian Therapeutics, Inc. - M&A Call 10/28/20 Earnings Revised 08/05/20 Miragen Therapeutics, Q2 2020 Earnings Call, Aug 05, 2020 08/05/20 Other Revised 06/23/20 Miragen Therapeutics - Special Call 06/23/20 Other Revised 05/21/20 Miragen Therapeutics, Inc. - Shareholder/Analyst Call 05/21/20 Earnings Revised 05/07/20 Miragen Therapeutics, Q1 2020 Earnings Call, May 07, 2020 05/07/20 Earnings Revised 03/11/20 Miragen Therapeutics, Inc., Q4 2019 Earnings Call, Mar 11, 2020 03/11/20
CY 2019
Other Revised 12/11/19 Miragen Therapeutics, Inc. - Special Call 12/11/19 Earnings Revised 11/07/19 Miragen Therapeutics, Inc., Q3 2019 Earnings Call, Nov 07, 2019 11/07/19 Earnings Revised 08/07/19 Miragen Therapeutics, Inc., Q2 2019 Earnings Call, Aug 07, 2019 08/07/19 Other Revised 06/19/19 Miragen Therapeutics, Inc. - Shareholder/Analyst Call 06/19/19 Earnings Revised 05/08/19 Miragen Therapeutics, Inc., Q1 2019 Earnings Call, May 08, 2019 05/08/19 Earnings Revised 03/13/19 Miragen Therapeutics, Inc., Q4 2018 Earnings Call, Mar 13, 2019 03/13/19
CY 2018
Earnings Revised 11/07/18 Miragen Therapeutics, Inc., Q3 2018 Earnings Call, Nov 07, 2018 11/07/18 Earnings Revised 08/07/18 Miragen Therapeutics, Inc., Q2 2018 Earnings Call, Aug 07, 2018 08/07/18 Other Revised 06/27/18 Miragen Therapeutics, Inc. - Shareholder/Analyst Call 06/27/18 Other Revised 05/23/18 Miragen Therapeutics, Inc. Presents at 2018 UBS Global Healthcare Conference, May-23-2018 10:00 AM 05/23/18 Earnings Revised 05/09/18 Miragen Therapeutics, Inc., Q1 2018 Earnings Call, May 09, 2018 05/09/18 Other Revised 05/08/18 Miragen Therapeutics, Inc. Presents at 43rd annual Deutsche Bank Healthcare Conference, May-08-2018 02:10 PM 05/08/18 Earnings Revised 03/14/18 Miragen Therapeutics, Inc., Q4 2017 Earnings Call, Mar 14, 2018 03/14/18
CY 2017
Earnings Revised 11/08/17 Miragen Therapeutics, Inc., Q3 2017 Earnings Call, Nov 08, 2017 11/08/17 Earnings Revised 08/11/17 Miragen Therapeutics, Inc., Q2 2017 Earnings Call, Aug 11, 2017 08/11/17